September 28, 2012

The Food and Drug Administration has approved a treatment for psoriasis of the scalp made by a subsidiary of British drug maker GlaxoSmithKline.

September 19, 2012

The Undy 5000 5K Run/Walk, presented by Dulcolax, returned to Philadelphia for the fifth consecutive year to help raise funds for colon cancer research.

September 19, 2012

A subsidiary of Johnson & Johnson is hoping to gain Food and Drug Administration approval for a new formulation of one of its drugs.

August 29, 2012

A panel of outside advisers to the Food and Drug Administration has backed wider use for Abbott Labs’ rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.

July 27, 2012

Horizon Pharma announced it has received regulatory approval from the Food and Drug Administration for one of its drugs.

July 17, 2012

A subsidiary of Johnson & Johnson is hoping to win an additional approval for one of its drugs.

June 26, 2012

An organization focused on Crohn's disease and ulcerative colitis has revamped its website, the group said Tuesday.

June 12, 2012

A Sanofi company is seeking regulatory approval from the Food and Drug Administration for a drug designed to treat relapsing multiple sclerosis.

June 1, 2012

An experimental drug for multiple sclerosis produced a noticeable reduction in symptoms of the disease in a late-stage clinical trial, the drug's developer said Friday.

May 24, 2012

Findings from a new study indicate that more than half of the patients with ulcerative colitis who received subcutaneous injections of a drug used to treat autoimmune disorders responded to the treatment.

May 18, 2012

PepsiCo's Frito-Lay North America division is developing a gluten-free validation process for its products as part of a multiyear initiative to assure consumers that many of the company's products are gluten free.

May 10, 2012

Generic drug maker Watson Pharmaceuticals is hoping to be the first to market a generic version of a drug used to treat ulcerative colitis, the company said.

April 20, 2012

Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.

April 19, 2012

Hidden Valley is updating the packaging on its salad dressing products to address gluten-sensitive and gluten-intolerant customers.

April 13, 2012

Gluten-free foods have exploded into the mainstream as more people see the foods as a healthier option. The Celiac Disease Foundation estimated that 17 million Americans may be gluten-intolerant. Millions more claim that avoiding gluten helps them control everything from arthritis to asthma.


February 23, 2012

The Cetaphil brand of cleansers and moisturizers has announced the launch of Cetaphil DermaControl products for acne-prone skin.

February 23, 2012

New research from Mintel suggested that the number of consumers that are gluten-intolerant/sensitive or have been diagnosed with celiac disease should be much greater.

February 16, 2012

The global market for celiac disease is expected to grow substantially over the decade as more people are diagnosed with the condition, according to a new report.

February 15, 2012

Botanical Labs on Tuesday introduced its gluten-free line of liquid dietary supplements across its Wellesse line of liquid supplements — calcium/magnesium, vitamin D3, iron and B-complex — at the Celiac Disease Foundation's South Florida Chapter Gluten-Free Expo in West Palm Beach, Fla.

December 21, 2011

An orally administered drug made by Genzyme for treating multiple sclerosis did not appear superior to a biotech drug already on the market, according to results of a late-stage clinical trial.

December 21, 2011

Drug maker Santarus has submitted a new drug application with the Food and Drug Administration for a treatment for ulcerative colitis, the company said.

December 20, 2011

Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

December 20, 2011

The market for drugs to treat ulcerative colitis will increase from 2010's $1.7 billion to $3 billion in 2020, according to a new report by market research firm Decision Resources.

November 14, 2011

A late-stage clinical trial of a drug under development as a treatment for multiple sclerosis has shown "successful" results.